Jianing Chen
Director of Finance/CFO chez IMAX CHINA HOLDING, INC.
Profil
Jianing Chen is currently the Chief Operating & Financial Officer at IMAX China Holding, Inc. Prior to this, she worked as the Chief Financial Officer at mProbe, Inc. from 2019 to 2023.
Chen holds a graduate degree from Oklahoma State University and an undergraduate degree from Jinan University.
Postes actifs de Jianing Chen
| Sociétés | Poste | Début |
|---|---|---|
| IMAX CHINA HOLDING, INC. | Director of Finance/CFO | 01/08/2023 |
Anciens postes connus de Jianing Chen
| Sociétés | Poste | Fin |
|---|---|---|
mProbe, Inc.
 mProbe, Inc. Medical/Nursing ServicesHealth Services mProbe, Inc. is a biotechnology company that focuses on precision medicine, precision health, and predictive healthcare analytics. The private company is based in Palo Alto, CA. The company has developed a proprietary technology platform that integrates artificial intelligence and multi-omic diagnostics to transform the disease prediction, prevention, and cure paradigm. The CEO of the company is Peter Limin. | Director of Finance/CFO | 01/08/2023 |
Formation de Jianing Chen
| Oklahoma State University | Graduate Degree |
| Jinan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMAX CHINA HOLDING, INC. | Electronic Technology |
| Entreprise privées | 1 |
|---|---|
mProbe, Inc.
mProbe, Inc. Medical/Nursing ServicesHealth Services mProbe, Inc. is a biotechnology company that focuses on precision medicine, precision health, and predictive healthcare analytics. The private company is based in Palo Alto, CA. The company has developed a proprietary technology platform that integrates artificial intelligence and multi-omic diagnostics to transform the disease prediction, prevention, and cure paradigm. The CEO of the company is Peter Limin. | Health Services |
